Actinobaccillus Pleuropneumoniae ApxII antibody and antigen (recombinant protein)

Diagnostic anti-Actinobaccillus Pleuropneumoniae ApxII antibodies pairs and antigen for animal health (animal Swine/Porcine/Pig infectious disease porcine pleuropneumonia) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Swine/Porcine/Pig disease testing products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-VT-P117-Tg001-Ag01 Recombinant Actinobaccillus Pleuropneumoniae ApxII protein $3090.00
GMP-VT-P117-Tg001-Ab01 Anti-Actinobaccillus Pleuropneumoniae ApxII mouse monoclonal antibody (mAb) $3090.00
GMP-VT-P117-Tg001-Ab02 Anti-Actinobaccillus Pleuropneumoniae ApxII mouse monoclonal antibody (mAb) $3090.00
GMP-VT-P117-Tg001-Ab03 Anti-Actinobaccillus Pleuropneumoniae ApxII human monoclonal antibody (mAb) $3090.00
GMP-VT-P117-Tg001-Ab04 Anti-Actinobaccillus Pleuropneumoniae ApxII human monoclonal antibody (mAb) $3090.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. GMP-VT-P117-Tg001-Ag01
Product Name Recombinant Actinobaccillus Pleuropneumoniae ApxII protein
Pathogen Actinobaccillus Pleuropneumoniae
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Actinobaccillus Pleuropneumoniae ApxII antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Actinobaccillus Pleuropneumoniae level test of animal Swine/Porcine/Pig infectious disease with porcine pleuropneumonia.
Tag His
Product description Recombinant Actinobaccillus Pleuropneumoniae ApxII proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. GMP-VT-P117-Tg001-Ab01,GMP-VT-P117-Tg001-Ab02
Pathogen Actinobaccillus Pleuropneumoniae
Product Name Anti-Actinobaccillus Pleuropneumoniae ApxII mouse monoclonal antibody (mAb)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Actinobaccillus Pleuropneumoniae ApxII antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Actinobaccillus Pleuropneumoniae antibodies in Actinobaccillus Pleuropneumoniae level test of animal Swine/Porcine/Pig infectious disease with porcine pleuropneumonia.
Product description Anti-Actinobaccillus Pleuropneumoniae ApxII mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Actinobaccillus Pleuropneumoniae antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. GMP-VT-P117-Tg001-Ab03,GMP-VT-P117-Tg001-Ab04
Pathogen Actinobaccillus Pleuropneumoniae
Product Name Anti-Actinobaccillus Pleuropneumoniae ApxII human monoclonal antibody (mAb)
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation Recombinant Actinobaccillus Pleuropneumoniae ApxII antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Actinobaccillus Pleuropneumoniae antibodies in Actinobaccillus Pleuropneumoniae level test of animal Swine/Porcine/Pig infectious disease with porcine pleuropneumonia.
Product description Anti-Actinobaccillus Pleuropneumoniae ApxII mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Pathogen Information


    The Significance of PCV2:

    Impact on Swine Industry: PCV2 is a member of the Circoviridae family and is primarily associated with post-weaning multisystemic wasting syndrome (PMWS), a severe disease in swine. It can also lead to other conditions such as porcine dermatitis and nephropathy syndrome (PDNS). PCV2 is highly prevalent in swine populations worldwide and is responsible for significant economic losses due to decreased productivity, increased mortality, and the cost of disease control measures.

    Genes and Proteins: As mentioned, PCV2 has critical genes and proteins that are essential for its structure, replication, and overall life cycle. The capsid protein, encoded by the capsid gene, is vital for the virus's ability to infect host cells. Replication-associated proteins play a crucial role in the virus's ability to replicate within the host, and the ORF-1 protein is involved in various essential viral functions.

    Diagnostic Methods:

    PCR-Based Tests: Your company can emphasize its role in developing advanced diagnostic tools, such as polymerase chain reaction (PCR) assays, which are highly sensitive and specific for PCV2 detection. These tests can help swine producers quickly identify infected animals and implement appropriate management strategies.

    Serological Assays: Highlight the development of serological assays like ELISAs that detect antibodies against PCV2. These tests can help in monitoring the prevalence of the virus within a herd and in assessing the effectiveness of vaccination programs.

    Vaccine Development:

    Vaccine Research: Showcase your company's commitment to research and development of PCV2 vaccines. PCV2 vaccines have been instrumental in reducing the impact of PCV2-associated diseases in swine herds. Your company's efforts in this area demonstrate a commitment to improving swine health and industry sustainability.

    Vaccine Efficacy: Emphasize the effectiveness of your PCV2 vaccines in preventing PCV2-associated diseases and reducing economic losses in swine production. Discuss any clinical trials and real-world success stories to illustrate the benefits of your vaccines.

    Economic Well-Being of the Swine Industry:

    Disease Management: Explain how effective diagnostic tools and vaccines can contribute to improved disease management in swine herds. This not only reduces mortality and morbidity but also enhances the overall economic well-being of the swine industry.

    Increased Productivity: Highlight how controlling PCV2 can lead to healthier and more productive swine herds, ultimately increasing meat production and profitability for swine producers.

    In your marketing materials, you can combine this information into a compelling narrative that conveys the significance of PCV2, the role of your company in addressing this issue, and the positive impact on the swine industry's health and economic prosperity. By doing so, you can position your biopharmaceutical company as a trusted partner in swine health and productivity.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.